COMPANY

Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical: recalling firm for Glutathione, as stated by public registers.

RECALLING FIRM

Recalled a product naming the peptide (FDA enforcement report).

GlutathioneClass II recall, Terminated, 2020-03-11 Regulator openFDA

What a register states, not an endorsement or an accusation by this site. All companies.

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.